| 0 |
FASCIOTOMY |
2 |
0.0179 |
| 1 |
OROPHARYNGEAL OEDEMA |
2 |
0.0138 |
| 2 |
INFUSION SITE COLDNESS |
1 |
0.0100 |
| 3 |
TISSUE INJURY |
3 |
0.0069 |
| 4 |
BLOOD FIBRINOGEN DECREASED |
7 |
0.0061 |
| 5 |
BULLOUS HAEMORRHAGIC DERMATOSIS |
1 |
0.0048 |
| 6 |
AGONAL RESPIRATION |
1 |
0.0035 |
| 7 |
SKIN GRAFT |
3 |
0.0032 |
| 8 |
SERUM SICKNESS |
7 |
0.0025 |
| 9 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
1 |
0.0022 |
| 10 |
PATIENT UNCOOPERATIVE |
1 |
0.0021 |
| 11 |
WOUND NECROSIS |
1 |
0.0021 |
| 12 |
PROTHROMBIN TIME PROLONGED |
9 |
0.0015 |
| 13 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
1 |
0.0013 |
| 14 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0012 |
| 15 |
TONGUE PRURITUS |
1 |
0.0012 |
| 16 |
THERAPY CHANGE |
10 |
0.0010 |
| 17 |
OROPHARYNGEAL SWELLING |
1 |
0.0010 |
| 18 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 19 |
KOUNIS SYNDROME |
2 |
0.0009 |
| 20 |
ANAPHYLACTOID REACTION |
3 |
0.0007 |
| 21 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 22 |
NECROSIS |
3 |
0.0005 |
| 23 |
COAGULOPATHY |
8 |
0.0005 |
| 24 |
SWELLING OF EYELID |
3 |
0.0005 |
| 25 |
EAR SWELLING |
1 |
0.0005 |
| 26 |
ANAPHYLACTIC REACTION |
24 |
0.0004 |
| 27 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 28 |
URTICARIA |
64 |
0.0004 |
| 29 |
SUBDURAL HAEMORRHAGE |
1 |
0.0004 |
| 30 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 31 |
STRIDOR |
1 |
0.0003 |
| 32 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 33 |
TYPE I HYPERSENSITIVITY |
1 |
0.0003 |
| 34 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 35 |
PARAESTHESIA ORAL |
4 |
0.0003 |
| 36 |
ARTERIOSPASM CORONARY |
1 |
0.0002 |
| 37 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 38 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 39 |
SKIN NECROSIS |
1 |
0.0002 |
| 40 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 41 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 42 |
CHOLECYSTITIS |
2 |
0.0002 |
| 43 |
ODYNOPHAGIA |
1 |
0.0002 |
| 44 |
UNDERDOSE |
11 |
0.0002 |
| 45 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 46 |
PRURITUS |
54 |
0.0001 |
| 47 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
4 |
0.0001 |
| 48 |
SWELLING FACE |
9 |
0.0001 |
| 49 |
ANGIOEDEMA |
6 |
0.0001 |
| 50 |
WHEEZING |
8 |
0.0001 |
| 51 |
HYPERTHERMIA |
1 |
0.0001 |
| 52 |
SHOCK |
3 |
0.0001 |
| 53 |
SWOLLEN TONGUE |
4 |
0.0001 |
| 54 |
INFUSION RELATED REACTION |
8 |
0.0001 |
| 55 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 56 |
SWELLING |
10 |
0.0001 |
| 57 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 58 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 59 |
TENDERNESS |
1 |
0.0001 |
| 60 |
SCRATCH |
1 |
0.0001 |
| 61 |
RENAL PAIN |
1 |
0.0001 |
| 62 |
LIP SWELLING |
3 |
0.0001 |
| 63 |
TACHYCARDIA |
8 |
0.0001 |
| 64 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 65 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 66 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 67 |
MOBILITY DECREASED |
6 |
0.0001 |
| 68 |
ERYTHEMA |
17 |
0.0001 |
| 69 |
BRAIN OEDEMA |
1 |
0.0001 |
| 70 |
FLUSHING |
8 |
0.0001 |
| 71 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 72 |
TACHYPNOEA |
1 |
0.0001 |
| 73 |
RASH |
32 |
0.0001 |
| 74 |
HYPERSENSITIVITY |
13 |
0.0001 |
| 75 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 76 |
CHEST DISCOMFORT |
7 |
0.0001 |
| 77 |
RASH ERYTHEMATOUS |
3 |
0.0001 |
| 78 |
CHOLELITHIASIS |
2 |
0.0001 |
| 79 |
FACE OEDEMA |
1 |
0.0001 |
| 80 |
NEUROTOXICITY |
1 |
0.0001 |
| 81 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 82 |
HYPOTENSION |
10 |
0.0000 |
| 83 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 84 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 85 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 86 |
SNEEZING |
1 |
0.0000 |
| 87 |
LIVER INJURY |
1 |
0.0000 |
| 88 |
CELLULITIS |
2 |
0.0000 |
| 89 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 90 |
RASH PRURITIC |
2 |
0.0000 |
| 91 |
OEDEMA |
2 |
0.0000 |
| 92 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 93 |
FEELING COLD |
1 |
0.0000 |
| 94 |
HAEMOPTYSIS |
1 |
0.0000 |
| 95 |
WOUND |
1 |
0.0000 |
| 96 |
NASAL CONGESTION |
2 |
0.0000 |
| 97 |
DISCOMFORT |
2 |
0.0000 |
| 98 |
DYSPNOEA |
18 |
0.0000 |
| 99 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 100 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 101 |
HAEMATURIA |
1 |
0.0000 |
| 102 |
HYPOXIA |
1 |
0.0000 |
| 103 |
CHEST PAIN |
5 |
0.0000 |
| 104 |
HYPERHIDROSIS |
3 |
0.0000 |
| 105 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 106 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 107 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 108 |
THERAPY CESSATION |
1 |
0.0000 |
| 109 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 110 |
BRADYCARDIA |
1 |
0.0000 |
| 111 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 112 |
BLISTER |
1 |
0.0000 |
| 113 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 114 |
IRRITABILITY |
1 |
0.0000 |
| 115 |
FEELING HOT |
1 |
0.0000 |
| 116 |
OFF LABEL USE |
14 |
0.0000 |
| 117 |
RHINORRHOEA |
1 |
0.0000 |
| 118 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 119 |
VOMITING |
7 |
0.0000 |
| 120 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 121 |
NAUSEA |
11 |
0.0000 |
| 122 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 123 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 124 |
CARDIAC FAILURE |
1 |
0.0000 |
| 125 |
MYALGIA |
2 |
0.0000 |
| 126 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 127 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 128 |
COUGH |
3 |
0.0000 |
| 129 |
ANXIETY |
3 |
0.0000 |
| 130 |
DYSPHAGIA |
1 |
0.0000 |
| 131 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 132 |
MIGRAINE |
1 |
0.0000 |
| 133 |
HEART RATE INCREASED |
1 |
0.0000 |
| 134 |
SYNCOPE |
1 |
0.0000 |
| 135 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 136 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 137 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 138 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 139 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 140 |
VISION BLURRED |
1 |
0.0000 |
| 141 |
PAIN |
4 |
0.0000 |
| 142 |
PARAESTHESIA |
1 |
0.0000 |
| 143 |
DIZZINESS |
3 |
0.0000 |
| 144 |
DEATH |
5 |
0.0000 |
| 145 |
PYREXIA |
2 |
0.0000 |
| 146 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 147 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 148 |
ARTHRALGIA |
2 |
0.0000 |
| 149 |
HYPERTENSION |
1 |
0.0000 |
| 150 |
MALAISE |
2 |
0.0000 |
| 151 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 152 |
INSOMNIA |
1 |
0.0000 |
| 153 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 154 |
ASTHENIA |
1 |
0.0000 |
| 155 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 156 |
HEADACHE |
1 |
0.0000 |
| 157 |
FATIGUE |
1 |
0.0000 |